Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -2113.85% is in line with its 1-year average of -2153.18%, near the high end of its 1-year range (-10765.90%–0.00%).
1.83% above its 12-month average of -2153.18%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -10765.90%.
OPERATING MARGIN
-2113.85%
OPERATING MARGIN AVG TTM
-2153.18%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.83%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Zenas BioPharma, Inc.
Market Cap
$1.70B
Operating Margin
-2113.85%
TTM Avg
-2153.18%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$1.71B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.71B
Operating Margin
-126.43%
TTM Avg
-103.56%
3Y Avg
-128.94%
5Y Avg
-107.63%
Market Cap
$1.73B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$1.73B
Operating Margin
10.91%
TTM Avg
-4.02%
3Y Avg
-27.30%
5Y Avg
-125.05%
Market Cap
$1.73B
Operating Margin
1.20%
TTM Avg
-1.69%
3Y Avg
-4.84%
5Y Avg
-5.86%
Market Cap
$1.73B
Operating Margin
-4454.21%
TTM Avg
-3427.90%
3Y Avg
-2683.37%
5Y Avg
-2097.52%
Market Cap
$1.74B
Operating Margin
-22.08%
TTM Avg
-25.82%
3Y Avg
-28.50%
5Y Avg
-19.36%
Market Cap
$1.75B
Operating Margin
11.89%
TTM Avg
11.48%
3Y Avg
12.13%
5Y Avg
11.99%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zenas BioPharma, Inc. (ZBIO) | $1.70B | -2113.85% | -2153.18% | 0.00% | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 11.69% | -8.16% | -10.59% | -4.68% |
| Personalis, Inc. (PSNL)vs › | $1.71B | -126.43% | -103.56% | -128.94% | -107.63% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | -651.67% | -787.38% | -968.58% | -820.03% |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.73B | 10.91% | -4.02% | -27.30% | -125.05% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.73B | 1.20% | -1.69% | -4.84% | -5.86% |
| Absci Corporation (ABSI)vs › | $1.73B | -4454.21% | -3427.90% | -2683.37% | -2097.52% |
| Novocure Ltd (NVCR)vs › | $1.74B | -22.08% | -25.82% | -28.50% | -19.36% |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 11.89% | 11.48% | 12.13% | 11.99% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 15.35% | 4.65% | 1.95% | -3.05% |
Gross Margin
100.0%
Operating Margin
-2113.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -10765.90% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -373.30% |
| 2024-12-31 | -1112.46% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 71.25% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
